Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
暂无分享,去创建一个
Paolo Zamboni | R. Mahajan | P. Zamboni | A. V. Singh | Bayani Uttara | Ajay V. Singh | R.T Mahajan | Bayani Uttara | A. Singh
[1] G. Heppner,et al. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. , 1986, Cancer research.
[2] K. Ingold,et al. Vitamin E as an in Vitro and in Vivo Antioxidant a , 1989, Annals of the New York Academy of Sciences.
[3] S. Loft,et al. Role of oxidative DNA damage in cancer initiation and promotion. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[4] C. Behl,et al. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Y. Henry,et al. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. , 1994, The Journal of biological chemistry.
[6] E. McGhee,et al. Natural antimutagenic agents. , 1996, Mutation research.
[7] C. Rae,et al. Changes in Hepatic Glutathione Metabolism in Diabetes , 1991, Diabetes.
[8] R. Floyd,et al. Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron , 1985, Neurochemical Research.
[9] E. Flamm,et al. The free radical pathology and the microcirculation in the major central nervous system disorders. , 1980, Acta physiologica Scandinavica. Supplementum.
[10] K. Davies,et al. Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.
[11] M. Mattson,et al. Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.
[12] N. Baquer,et al. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. , 1993, Biochemical pharmacology.
[13] J. Cooper,et al. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. , 2000, Human molecular genetics.
[14] W. Pryor,et al. Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. , 1992, Free radical biology & medicine.
[15] A. Bush,et al. Metals and neuroscience. , 2000, Current opinion in chemical biology.
[16] D. Butterfield,et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.
[17] U. Bandyopadhyay,et al. Reactive oxygen species: oxidative damage and pathogenesis , 1999 .
[18] I. Fridovich. Fundamental Aspects of Reactive Oxygen Species, or What's the Matter with Oxygen? , 1999, Annals of the New York Academy of Sciences.
[19] J. Cadet. Free radical mechanisms in the central nervous system: an overview. , 1988, The International journal of neuroscience.
[20] D Kromhout,et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.
[21] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[22] M. Mattson. Will caloric restriction and folate protect against AD and PD? , 2003, Neurology.
[23] B. D. Oomah,et al. Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain Products , 1998 .
[24] M. Recio,et al. Anti‐inflammatory and antioxidant properties of Helichrysum italicum , 2002, The Journal of pharmacy and pharmacology.
[25] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[26] T. Yoshikawa. Free radicals and their scavengers in Parkinson's disease. , 1993, European neurology.
[27] Deborah Gustafson,et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.
[28] M. Youdim,et al. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. , 1994, Life sciences.
[29] Colin L. Masters,et al. Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.
[30] Xudong Huang,et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.
[31] W. Burke,et al. Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells. , 1994, Life sciences.
[32] B. Halliwell,et al. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? , 1994, The Lancet.
[33] C. Négre. [Treatment of Parkinson's disease]. , 1986, Soins; la revue de reference infirmiere.
[34] G. Storz,et al. Redox sensing by prokaryotic transcription factors. , 2000, Biochemical pharmacology.
[35] G. L. West,et al. Iron overload in Africa. Interaction between a gene and dietary iron content. , 1992, The New England journal of medicine.
[36] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[37] M. W. Anders,et al. Targeting antioxidants to mitochondria: a new therapeutic direction. , 2006, Biochimica et biophysica acta.
[38] C. Masters,et al. Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid , 2002, The Journal of Biological Chemistry.
[39] V. Papadopoulos,et al. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.
[40] C. S. Yang,et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. , 2001, Annual review of nutrition.
[41] R. Martins,et al. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β , 2003, Brain Research Reviews.
[42] R. Salganik. The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population , 2001, Journal of the American College of Nutrition.
[43] B Chance,et al. Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.
[44] S. Imam,et al. Possible Mechanism for the Neuroprotective Effects of l‐Carnitine on Methamphetamine‐Evoked Neurotoxicity , 2003, Annals of the New York Academy of Sciences.
[45] J. McCord,et al. The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.
[46] E. Morgan,et al. The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.
[47] S. Y. Wang,et al. Antioxidant activity and phenolic compounds in selected herbs. , 2001, Journal of agricultural and food chemistry.
[48] J. Stamler,et al. Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.
[49] K. Wakamatsu,et al. The structure of neuromelanin as studied by chemical degradative methods , 2003, Journal of neurochemistry.
[50] H. Hirt,et al. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. , 2004, Annual review of plant biology.
[51] Jürgen Götz,et al. Glial cells under physiologic and pathologic conditions. , 2002, Archives of neurology.
[52] B. Mossman,et al. Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells. , 1991, Cancer research.
[53] B. Ames,et al. Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] Patrik Brundin,et al. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. , 2002, Human molecular genetics.
[55] Y. Muramatsu,et al. Age-related changes in the concentrations of major and trace elements in the brain of rats and mice , 2001, Biological Trace Element Research.
[56] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[57] Guoyao Wu,et al. Free radicals, antioxidants, and nutrition. , 2002, Nutrition.
[58] B. Winblad,et al. Treating the full spectrum of dementia with memantine , 2003, International journal of geriatric psychiatry.
[59] J. Valentine,et al. Misfolded CuZnSOD and amyotrophic lateral sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[60] I. Young,et al. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. , 1995, Free radical biology & medicine.
[61] R. Mason,et al. The origin of the hydroxyl radical oxygen in the Fenton reaction. , 1997, Free radical biology & medicine.
[62] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[63] C. Gérard,et al. Complexes of iron(III) with ligands of biological interest: dopamine and 8-hydroxyquinoline-5-sulphonic acid , 1994 .
[64] D. Harman,et al. Free‐Radical Theory of Aging , 1994, Antioxidants & redox signaling.
[65] V. Papadopoulos,et al. The Ginkgo biloba extract EGB 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2000, Neurobiology of Aging.
[66] J. Simpkins,et al. Neuroprotective effects of estrogens: potential mechanisms of action , 2000, International Journal of Developmental Neuroscience.
[67] B. P. Yu,et al. Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.
[68] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[69] B. Halliwell,et al. Antioxidants in human health and disease. , 1996, Annual review of nutrition.
[70] H. Bartsch,et al. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. , 2000, European journal of cancer.
[71] R. Floyd,et al. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress , 1992, Annals of neurology.
[72] K. C. Chang,et al. Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[73] J. Pommery,et al. Antioxidant properties of hydroxy-flavones. , 1996, Free radical biology & medicine.
[74] S. Kuo,et al. Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.
[75] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[76] A. Axon,et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. , 1991, Carcinogenesis.
[77] Xianzhong Wu,et al. Antioxidant and antiproliferative activities of common fruits. , 2002, Journal of agricultural and food chemistry.
[78] K. Kohn,et al. Activated neutrophils induce prolonged DNA damage in neighboring cells. , 1989, Carcinogenesis.
[79] E. Melamed,et al. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.
[80] G. Yarrington. Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.
[81] Mei Sun,et al. Antioxidant activity of betalains from plants of the amaranthaceae. , 2003, Journal of agricultural and food chemistry.
[82] Mark P Mattson,et al. Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders , 2004, Annals of the New York Academy of Sciences.
[83] H. Schipper. Redox Neurology: Visions of an Emerging Subspecialty , 2004, Annals of the New York Academy of Sciences.
[84] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[85] R. Floyd,et al. Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. , 1997, Advances in pharmacology.
[86] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[87] K. Hensley,et al. Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.
[88] S. Singh,et al. Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture , 2005, Brain Research.
[89] A. Ceriello. Oxidative stress and glycemic regulation. , 2000, Metabolism: clinical and experimental.
[90] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.